title: Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin.
authors.forename: C J
authors.initials: CJ
authors.lastname: Weegink
authors.forename: R A
authors.initials: RA
authors.lastname: Chamuleau
authors.forename: H W
authors.initials: HW
authors.lastname: Reesink
authors.forename: D S
authors.initials: DS
authors.lastname: Molenaar
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000209:etiology*; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin